XENETIC BIOSCIENCES, INC. Deferred Tax Liabilities, Goodwill and Intangible Assets
XENETIC BIOSCIENCES, INC. (XBIO) had Deferred Tax Liabilities, Goodwill and Intangible Assets of $3.26 million as of 2013-12-31, per its 10-K filed 2015-07-20.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Gross › Deferred Tax Liabilities, Goodwill and Intangible Assets
us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets · last filed 2015-07-20
- 2013-12-31: Deferred Tax Liabilities, Goodwill and Intangible Assets $3.26M.
- 2012-12-31: Deferred Tax Liabilities, Goodwill and Intangible Assets $3.19M.
| Period end | Deferred Tax Liabilities, Goodwill and Intangible Assets |
|---|---|
| 2013-12-31 | $3.26M 10-K · filed 2015-07-20 |
| 2012-12-31 | $3.19M 10-K · filed 2015-07-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |